"Prostatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PROSTATE.
| Descriptor ID |
D011471
|
| MeSH Number(s) |
C04.588.945.440.770 C12.294.260.750 C12.294.565.625 C12.758.409.750
|
| Concept/Terms |
Prostatic Neoplasms- Prostatic Neoplasms
- Prostate Neoplasms
- Neoplasms, Prostate
- Neoplasm, Prostate
- Prostate Neoplasm
- Neoplasms, Prostatic
- Neoplasm, Prostatic
- Prostatic Neoplasm
Prostate Cancer- Prostate Cancer
- Cancer, Prostate
- Cancers, Prostate
- Prostate Cancers
- Cancer of the Prostate
- Prostatic Cancer
- Cancer, Prostatic
- Cancers, Prostatic
- Prostatic Cancers
- Cancer of Prostate
|
Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms".
This graph shows the total number of publications written about "Prostatic Neoplasms" by people in this website by year, and whether "Prostatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 14 | 0 | 14 |
| 1997 | 9 | 2 | 11 |
| 1998 | 19 | 1 | 20 |
| 1999 | 16 | 2 | 18 |
| 2000 | 21 | 2 | 23 |
| 2001 | 32 | 2 | 34 |
| 2002 | 19 | 1 | 20 |
| 2003 | 39 | 4 | 43 |
| 2004 | 39 | 4 | 43 |
| 2005 | 33 | 0 | 33 |
| 2006 | 33 | 1 | 34 |
| 2007 | 45 | 3 | 48 |
| 2008 | 36 | 2 | 38 |
| 2009 | 40 | 4 | 44 |
| 2010 | 33 | 6 | 39 |
| 2011 | 34 | 3 | 37 |
| 2012 | 30 | 6 | 36 |
| 2013 | 39 | 2 | 41 |
| 2014 | 32 | 8 | 40 |
| 2015 | 36 | 3 | 39 |
| 2016 | 37 | 5 | 42 |
| 2017 | 25 | 4 | 29 |
| 2018 | 24 | 2 | 26 |
| 2019 | 29 | 1 | 30 |
| 2020 | 26 | 1 | 27 |
| 2021 | 30 | 1 | 31 |
| 2022 | 25 | 1 | 26 |
| 2023 | 21 | 1 | 22 |
| 2024 | 16 | 1 | 17 |
| 2025 | 15 | 2 | 17 |
| 2026 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prostatic Neoplasms" by people in Profiles.
-
MITF Gain-of-Function Mutation in Metastatic Prostate Cancer: A Rare Finding With Potential Therapeutic Significance. Cancer Rep (Hoboken). 2026 Jun; 9(6):e70588.
-
Nanoplasmid PSMA DNA vaccine primes antitumor immunity and enhances response to PD-1 blockade against prostate cancer. Cancer Lett. 2026 Sep 01; 655:218591.
-
Noisy probing dose facilitated dose prediction for pencil beam scanning proton therapy: Physics enhances generalizability. Med Phys. 2026 May; 53(5):e70509.
-
The hexosamine biosynthetic pathway alters the cytoskeleton to modulate cell proliferation and migration in aggressive prostate cancer. Cell Commun Signal. 2026 Mar 28; 24(1).
-
DHODH links mitochondrial bioenergetics, one-carbon metabolism, and DNA repair to sustain aggressive prostate adenocarcinoma. Cell Commun Signal. 2026 Jan 29; 24(1).
-
Rectal spacers in high-dose-rate-brachytherapy: Optimizing peripheral zone radiation delivery. Brachytherapy. 2026 Mar-Apr; 25(2):396-401.
-
To Space or Not to Space: The EPIC Question for Prostate Stereotactic Radiation Therapy With or Without Hydrogel Rectal Spacer. Pract Radiat Oncol. 2026 May-Jun; 16(3):276-288.
-
Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations. Eur Urol Focus. 2026 Jan; 12(1):16-18.
-
Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancer. Oncogene. 2025 12; 44(50):4868-4877.
-
Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study. Ann Oncol. 2026 01; 37(1):53-68.